home / stock / pmvp / pmvp quote
Last: | $1.99 |
---|---|
Change Percent: | -2.67% |
Open: | $1.92 |
Close: | $1.99 |
High: | $2.0102 |
Low: | $1.89 |
Volume: | 1,268,663 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.99 | $1.92 | $1.99 | $2.0102 | $1.89 | 1,268,663 | 05-03-2024 |
$1.87 | $1.87 | $1.87 | $1.915 | $1.83 | 292,245 | 05-02-2024 |
$1.86 | $1.81 | $1.86 | $1.88 | $1.805 | 426,501 | 05-01-2024 |
$1.8 | $1.76 | $1.8 | $1.83 | $1.725 | 217,658 | 04-30-2024 |
$1.77 | $1.76 | $1.77 | $1.84 | $1.75 | 263,319 | 04-29-2024 |
$1.75 | $1.72 | $1.75 | $1.77 | $1.69 | 336,037 | 04-26-2024 |
$1.71 | $1.67 | $1.71 | $1.72 | $1.655 | 348,250 | 04-25-2024 |
$1.69 | $1.8 | $1.69 | $1.8 | $1.69 | 201,872 | 04-24-2024 |
$1.805 | $1.73 | $1.805 | $1.85 | $1.71 | 371,068 | 04-23-2024 |
$1.73 | $1.62 | $1.73 | $1.755 | $1.6 | 538,724 | 04-22-2024 |
$1.61 | $1.6 | $1.61 | $1.655 | $1.58 | 479,632 | 04-19-2024 |
$1.62 | $1.64 | $1.62 | $1.66 | $1.58 | 464,028 | 04-18-2024 |
$1.61 | $1.6 | $1.61 | $1.66 | $1.6 | 277,479 | 04-17-2024 |
$1.6 | $1.6 | $1.6 | $1.645 | $1.57 | 330,783 | 04-16-2024 |
$1.635 | $1.81 | $1.635 | $1.81 | $1.61 | 585,959 | 04-15-2024 |
$1.79 | $1.66 | $1.79 | $1.82 | $1.64 | 1,703,346 | 04-12-2024 |
$1.58 | $1.53 | $1.58 | $1.6 | $1.52 | 295,424 | 04-11-2024 |
$1.51 | $1.54 | $1.51 | $1.575 | $1.49 | 411,643 | 04-10-2024 |
$1.58 | $1.56 | $1.58 | $1.605 | $1.52 | 355,988 | 04-09-2024 |
$1.56 | $1.61 | $1.56 | $1.615 | $1.51 | 521,182 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
PMV Pharmaceuticals Inc. Company Name:
PMVP Stock Symbol:
NASDAQ Market:
2024-04-11 21:15:01 ET Jefferies analyst issues BUY recommendation for PMVP on April 11, 2024 07:46PM ET. PMVP was trading at $1.58 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendations ...
2024-04-11 21:00:03 ET Kambiz Yazdi from Jefferies issued a price target of $5.00 for PMVP on 2024-04-11 19:46:00. The adjusted price target was set to $5.00. At the time of the announcement, PMVP was trading at $1.58. The overall price target consensus is at $31.33 with...
Rezatapopt is a first-in-class precision oncology investigational therapy for patients with advanced solid tumors with a TP53 Y220C mutation and KRAS wild-type (WT) First patient dosed in Phase 2 portion of the PYNNACLE trial which will assess rezatapopt as monotherapy in patients...